<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Problems of Virology</journal-id><journal-title-group><journal-title xml:lang="en">Problems of Virology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы вирусологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0507-4088</issn><issn publication-format="electronic">2411-2097</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">578</article-id><article-id pub-id-type="doi">10.36233/0507-4088-63</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Specific features of the pathology of the respiratory system in SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus) infected Syrian hamsters (Mesocricetus auratus)</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности патологии дыхательной системы у сирийских хомяков (Mesocricetus auratus) при инфекции вирусом SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5324-512X</contrib-id><name-alternatives><name xml:lang="en"><surname>Chepur</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Чепур</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0924-9158</contrib-id><name-alternatives><name xml:lang="en"><surname>Alekseeva</surname><given-names>I. I.</given-names></name><name xml:lang="ru"><surname>Алексеева</surname><given-names>И. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8703-6799</contrib-id><name-alternatives><name xml:lang="en"><surname>Vladimirova</surname><given-names>O. O.</given-names></name><name xml:lang="ru"><surname>Владимирова</surname><given-names>О. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7232-4678</contrib-id><name-alternatives><name xml:lang="en"><surname>Myasnikov</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Мясников</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6974-5583</contrib-id><name-alternatives><name xml:lang="en"><surname>Tyunin</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Тюнин</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7406-753X</contrib-id><name-alternatives><name xml:lang="en"><surname>Ilinskii</surname><given-names>N. S.</given-names></name><name xml:lang="ru"><surname>Ильинский</surname><given-names>Н. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1372-369X</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikishin</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Никишин</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Aleksandr S. Nikishin, </bold>Researcher</p><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p><bold>Никишин Александр Сергеевич,</bold> научный сотрудник</p><p>195043, Санкт-Петербург, Россия</p></bio><email>nikishin1664@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6984-2914</contrib-id><name-alternatives><name xml:lang="en"><surname>Shevchenko</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Шевченко</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0483-5032</contrib-id><name-alternatives><name xml:lang="en"><surname>Smirnova</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Смирнова</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>195043, Saint Petersburg, Russia</p></bio><bio xml:lang="ru"><p>195043, Санкт-Петербург, Россия</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">FSBI «State Research Testing Institute of Military Medicine» of the Ministry of Defense of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Государственный научно-исследовательский испытательный институт военной медицины» Министерства обороны Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-12-09" publication-format="electronic"><day>09</day><month>12</month><year>2021</year></pub-date><volume>66</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>442</fpage><lpage>451</lpage><history><date date-type="received" iso-8601-date="2022-01-08"><day>08</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Chepur S.V., Alekseeva I.I., Vladimirova O.O., Myasnikov V.A., Tyunin M.A., Ilinskii N.S., Nikishin A.S., Shevchenko V.A., Smirnova A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Чепур С.В., Алексеева И.И., Владимирова О.О., Мясников В.А., Тюнин М.А., Ильинский Н.С., Никишин А.С., Шевченко В.А., Смирнова А.В.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Chepur S.V., Alekseeva I.I., Vladimirova O.O., Myasnikov V.A., Tyunin M.A., Ilinskii N.S., Nikishin A.S., Shevchenko V.A., Smirnova A.V.</copyright-holder><copyright-holder xml:lang="ru">Чепур С.В., Алексеева И.И., Владимирова О.О., Мясников В.А., Тюнин М.А., Ильинский Н.С., Никишин А.С., Шевченко В.А., Смирнова А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://virusjour.crie.ru/jour/article/view/578">https://virusjour.crie.ru/jour/article/view/578</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Verification of histological changes in respiratory system using Syrian (golden) hamsters (Mesocricetus auratus) as experimental model is an important task for preclinical studies of drugs intended for prevention and treatment of the novel coronavirus infection COVID-19.</p><p><bold>The aim of this work </bold>was to study pathological changes of pulmonary tissue in SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) experimental infection in Syrian hamsters. Material and methods. Male Syrian hamsters weighting 80–100 g were infected by intranasal administration of culture SARS-CoV-2 at dose 4 × 104 TCID50/ml (TCID is tissue culture infectious dose). Animals were euthanatized on 3, 7 and 14 days after infection, with gravimetric registration. The viral load in lungs was measured using the polymerase chain reaction (PCR). Right lung and trachea tissues were stained with hematoxylin-eosin and according to Mallory.</p><p><bold>Results and discussion. </bold>The highest viral replicative activity in lungs was determined 3 days after the infection. After 7 days, on a background of the decrease of the viral load in lungs, a pathologically significant increase of the organ’s gravimetric parameters was observed. Within 3 to 14 days post-infection, the lung histologic pattern had been showing the development of inflammation with a succession of infiltrative-proliferative, edematousmacrophagal and fibroblastic changes. It was found that initial changes in respiratory epithelium can proceed without paranecrotic interstitial inflammation, while in the formation of multiple lung parenchyma lesions, damage to the epithelium of bronchioles and acinar ducts can be secondary. The appearance of epithelioid large-cell metaplastic epithelium, forming pseudoacinar structures, was noted as a pathomorphological feature specific to SARS-CoV-2 infection in Syrian hamsters.</p><p><bold>Conclusion. </bold>As a result of the study, the specific features of the pathology of the respiratory system in SARSCoV-2 infected Syrian hamsters were described. These findings are of practical importance as reference data that can be used for preclinical studies to assess the effectiveness of vaccines and potential drugs.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> На сегодняшний день в связи с необходимостью проведения доклинических исследований препаратов, предназначенных для профилактики и лечения новой коронавирусной инфекции COVID-19, важной задачей представляется верификация гистологических изменений дыхательной системы на экспериментальных моделях у лабораторных животных, в частности у сирийских (золотистых) хомяков (Mesocricetus auratus).</p><p><bold>Цель работы</bold> – исследование патологических изменений лёгких применительно к биологической модели инфекции, вызываемой вирусом SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus), у сирийских хомяков.</p><p><bold>Материал и методы. </bold>Самцов сирийских хомяков массой 80–100 г заражали путём интраназального введения культуры с содержанием возбудителя 4 × 104 ТЦД50/мл (ТЦД – тканевая цитопатическая доза). Эвтаназию животных проводили на 3, 7 и 14 сут с регистрацией гравиметрических показателей. Содержание вируса в лёгких определяли методом полимеразной цепной реакции (ПЦР). Гистологические препараты ткани правого лёгкого и трахеи окрашивали гематоксилином и эозином, а также по Маллори.</p><p><bold>Результаты и обсуждение. </bold>У инфицированных SARS-CoV-2 животных через 3 сут после заражения определяли максимальные значения репликативной активности вируса в лёгочной ткани. Спустя 7 сут на фоне снижения количественного содержания инфекционного агента в тканях лёгкого выявляли патологически значимое увеличение гравиметрических показателей органа. В период 3–14 сут после заражения в гистологической картине лёгких наблюдали развитие воспалительного процесса, характеризовавшегося последовательной сменой инфильтративно-пролиферативных, отёчно-макрофагальных и фибробластических изменений. Установлено, что начальные изменения эпителия дыхательных путей могут протекать без паранекротического интерстициального воспаления, тогда как при формировании множественного поражения лёгочной паренхимы повреждения эпителия бронхиол и ацинарных ходов могут иметь вторичный характер. В качестве патоморфологического признака, характерного для инфекции SARS-CoV-2 у данного вида, отмечено появление эпителиоидных крупноклеточных форм метаплазированного эпителия, формирующих псевдоацинарные структуры.</p><p><bold>Заключение. </bold>В результате исследования описаны особенности патологии дыхательной системы у сирийских хомяков на экспериментальной модели инфекции SARS-CoV-2. Полученные данные имеют практическое значение как референтные и могут быть использованы при проведении доклинических исследований по оценке эффективности вакцинных препаратов и лекарственных средств.</p></trans-abstract><kwd-group xml:lang="en"><kwd>SARS-CoV-2</kwd><kwd>histological changes</kwd><kwd>respiratory system</kwd><kwd>lungs</kwd><kwd>infiltration macrophages</kwd><kwd>alveolocyte metaplasia</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>SARS-CoV-2</kwd><kwd>гистологические изменения</kwd><kwd>дыхательная система</kwd><kwd>лёгкие</kwd><kwd>инфильтрация</kwd><kwd>макрофаги</kwd><kwd>метаплазия альвеолоцитов</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счёт государственного бюджета</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Чепур С.В., Плужников Н.Н., Чубарь О.В., Бакулина Л.С., Литвиненко И.В., Макаров В.А., и др. Респираторные РНК-вирусы: как подготовиться к встрече с новыми пандемическими штаммами. Успехи соврем. биологии. 2020; 140(4): 359–77. https://doi.org/10.31857/S0042132420040043</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Bradley B.T., Maioli H., Johnston R., Chaudhry I., Fink S.L., Xu P.H., et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet. 2020; 396(10247): 320–32. https://doi.org/10.1016/S0140-6736(20)31305-2</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Чучалин А.Г. COVID-19 пневмония: лекция для студентов ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова»; 2020. Available at: https://youtu.be/hTVZSwa7X5c (accessed October 14, 2021).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Becker R.C. COVID-19-associated vasculitis and vasculopathy. J. Thromb. Thrombolysis. 2020; 50(3): 499–511. https://doi.org/10.1007/s11239-020-02230-4</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Calabrese F., Pezzuto F., Fortarezza F., Hofman P., Kern I., Panizo A., et al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 2020; 477(3): 359–72. https://doi.org/10.1007/s00428-020-02886-6</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.Y. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J. Thorac. Oncol. 2020; 15(5):700–4. https://doi.org/10.1016/j.jtho.2020.02.010</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Li M., Lei P., Zeng B., Li Z., Yu P., Fan B., et al. Coronavirus Disease (COVID-19): Spectrum of CT findings and temporal progression of the disease. Acad. Radiol. 2020; 27(5): 603–8. https://doi.org/10.1016/j.acra.2020.03.003</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Bernheim A., Mei X., Huang M., Yang Y., Fayad Z.A., Zhang N., et al. Chest CT findings in Coronavirus Disease-19 (COVID-19):Relationship to duration of infection. Radiology. 2020; 295(3):685–91. https://doi.org/10.1148/radiol.2020200463</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Pan F., Ye T., Sun P., Gui S., Liang B., Li L., et al. Time course of lung changes at chest CT during recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020; 295(3): 715–21. https://doi.org/10.1148/radiol.2020200370</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Liu H., Liu F., Li J., Zhang T., Wanga D., Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J. Infect. 2020; 80(5): e7–13. https://doi.org/10.1016/j.jinf.2020.03.007</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Meng H., Xiong R., He R., Weichen L., Bo H., Lin Z., et al. CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China. J. Infect. 2020; 81(1):e33–9. https://doi.org/10.1016/j.jinf.2020.04.004</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Mohanty S.K., Satapathy A., Naidu M.M., Mukhopadhyay S., Sharma S., Barton L.M., et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge. Diagn. Pathol. 2020; 15(1): 103. https://doi.org/10.1186/s13000-020-01017-8</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Iba T., Connors J.M., Levy J.H. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm. Res. 2020; 69(12): 1181–9. https://doi.org/10.1007/s00011-020-01401-6</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Zhang H., Zhou P., Wei Y., Yue H., Wang Y., Hu M., et al. Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann. Intern. Med. 2020; 172(9): 629–32. https://doi.org/10.7326/M20-0533</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417–8. https://doi.org/10.1016/S0140-6736(20)30937-5</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Jain A. COVID-19 and lung pathology. Indian J. Pathol. Microbiol. 2020; 63(2): 171–2. https://doi.org/10.4103/IJPM.IJPM_280_20</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Rizzo P., Vieceli Dalla Sega F., Fortini F., Marracino L., Rapezzi C., Ferrari R., et al. COVID-19 in the heart and the lungs: could we «Notch» the inflammatory storm? Basic Res. Cardiol. 2020; 115(3):31. https://doi.org/10.1007/s00395-020-0791-5</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Nicolai L., Leunig A., Brambs S., Kaiser R., Weinberger T., Weigand M., et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020; 142(12): 1176–89. https://doi.org/10.1161/CIRCULATIONAHA.120.048488</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Sun R., Liu H., Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J. Radiol. 2020; 21(5): 541–4. https://doi.org/10.3348/kjr.2020.0180</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Rosenke K., Meade-White K., Letko M., Clancy C., Hansen F., Liu Y., et al. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg. Microbes Infect. 2020; 9(1): 2673–84. https://doi.org/10.1080/22221751.2020.1858177</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Imai M., Iwatsuki-Horimoto K., Hatta M., Loeber S., Halfmann P.J., et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl. Acad. Sci. USA. 2020; 117(28): 16587–95. https://doi.org/10.1073/pnas.2009799117</mixed-citation></ref></ref-list></back></article>
